Today's Veterinary Practice

NOV-DEC 2015

Today's Veterinary Practice provides comprehensive information to keep every small animal practitioner up to date on companion animal medicine and surgery as well as practice building and management.

Issue link: http://todaysveterinarypractice.epubxp.com/i/591321

Contents of this Issue

Navigation

Page 18 of 107

Interceptor, Elanco and the diagonal bar are trademarks owned by or licensed to Eli Lilly and Company, its affi liates or subsidiaries. Heartgard is a registered trademark of Merial. © Eli Lilly and Company, its affi liates or subsidiaries. USCAHINP00012 IMPORTANT SAFETY INFORMATION Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Interceptor Plus, dogs should be tested for existing heartworm infections. The safety of Interceptor Plus has not been evaluated in dogs used for breeding or in lactating females. The following adverse reactions have been reported in dogs after administration of milbemycin oxime or praziquantel: vomiting, diarrhea, depression/ lethargy, ataxia, weight loss, convulsions, weakness, and salivation. For product label, including complete safety information, see page XX. CHOOSE THE CHEW WITH MORE PROTECTION THAN HEARTGARD ® PLUS A soft, fl avored chewable tablet that takes broad-spectrum protection even further with the proven power of milbemycin oxime to protect dogs against some common intestinal parasites and heartworm disease. The addition of praziquantel boosts coverage even more to include tapeworms for broad-spectrum parasite control. Prevents heartworm disease and treats and controls adult hookworm (A. caninum), roundworm, whipworm and tapeworm infections in dogs. Safe for use in dogs and puppies 6 weeks of age and older and 2 lbs of weight or greater. (ivermectin/pyrantel) New! 16

Articles in this issue

Archives of this issue

view archives of Today's Veterinary Practice - NOV-DEC 2015